Compare LE & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LE | BIOA |
|---|---|---|
| Founded | 1963 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.9M | 255.6M |
| IPO Year | 1994 | 2024 |
| Metric | LE | BIOA |
|---|---|---|
| Price | $9.57 | $5.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $19.00 | ★ $32.56 |
| AVG Volume (30 Days) | 151.8K | ★ 824.7K |
| Earning Date | 12-08-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.21 |
| EPS | ★ 10.96 | N/A |
| Revenue | ★ $1,162,769,000.00 | $8,995,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.10 | $97.72 |
| P/E Ratio | $0.89 | ★ N/A |
| Revenue Growth | ★ 0.72 | N/A |
| 52 Week Low | $9.56 | $4.81 |
| 52 Week High | $20.04 | $25.96 |
| Indicator | LE | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 28.22 |
| Support Level | N/A | $4.81 |
| Resistance Level | $10.78 | $8.53 |
| Average True Range (ATR) | 0.40 | 0.37 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 5.58 | 15.82 |
Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.